↓ Skip to main content

Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

Overview of attention for article published in Pediatric Rheumatology, September 2011
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
15 Mendeley